Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Madame Bioscience PCL's quarterly market cap
declined
from Sep. 2025 (฿848 Mil) to Dec. 2025 (฿565 Mil) and
declined
from Dec. 2025 (฿565 Mil) to Mar. 2026 (฿485 Mil).
Madame Bioscience PCL's annual market cap
increased
from Dec. 2023 (฿569 Mil) to Dec. 2024 (฿755 Mil) but then
declined
from Dec. 2024 (฿755 Mil) to Dec. 2025 (฿565 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Madame Bioscience PCL's Enterprise Value for Today is ฿653 Mil.
Madame Bioscience PCL (BKK:MADAME) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Madame Bioscience PCL's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Madame Bioscience PCL Market Cap vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Madame Bioscience PCL's Market Cap distribution charts can be found below:
* The bar in red indicates where Madame Bioscience PCL's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Madame Bioscience PCL's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Madame Bioscience PCL (BKK:MADAME) has a Market Cap of ฿501 Mil as of Jul. 21, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Madame Bioscience PCL and its competitors. According to the industry distribution chart, Madame Bioscience PCL ranks #1644 out of 2048 companies in the Consumer Packaged Goods industry, placing it in the top 80.3%.
Is Madame Bioscience PCL's Market Cap too high?
Madame Bioscience PCL's current Market Cap is ฿501 Mil. Based on the distribution chart, Madame Bioscience PCL ranks #1644 out of 2048 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Madame Bioscience PCL has a GF Score™ of 21/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Madame Bioscience PCL's Market Cap compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Madame Bioscience PCL ranks #1644 out of 2048 companies for Market Cap. This places Madame Bioscience PCL in the lower half of its industry. The industry median Market Cap is 101.73. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Consumer Packaged Goods company?
The median Market Cap among Consumer Packaged Goods companies is 101.73, based on 2,048 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Madame Bioscience PCL and its competitors. For the Consumer Packaged Goods industry, the median Market Cap is 101.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Madame Bioscience PCL's current Market Cap is ฿501 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Madame Bioscience PCL stock overvalued right now?
Based on GuruFocus' analysis, Madame Bioscience PCL (BKK:MADAME) is currently considered Fairly Valued. The stock's GF Value™ is ฿0.64, compared to a current price of ฿0.62 — trading 3.1% below its estimated fair value. The current Market Cap is ฿501 Mil. Madame Bioscience PCL's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Madame Bioscience PCL (BKK:MADAME), the current Market Cap is ฿501 Mil as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Madame Bioscience PCL (BKK:MADAME) Overvalued in 2026?
Based on GuruFocus' analysis, Madame Bioscience PCL stock appears to be undervalued.
The current stock price of ฿0.62 is trading 3.1% below its estimated GF Value™ of ฿0.64.
GuruFocus considers Madame Bioscience PCL to be Fairly Valued.
Key valuation signals for BKK:MADAME:
Market Cap: ฿501 Mil
GF Value™: ฿0.64 vs. price of ฿0.62 (3.1% below fair value)
No single metric tells the full story. See the BKK:MADAME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Madame Bioscience PCL is engaged in the segments of the Packaging business, Food business, Retail sales of cosmetics, and Other businesses. Its activities include the manufacturing and selling of plastic packaging, restaurant business, advertising rental service in the gas station and manufacturing and selling of dried fruits, among others. The group derives a majority of its revenue from the Food business. The firm's product portfolio includes Ready meals, Frozen food, value-added seafood and vegetables, Flexible packaging, and PET Bottles.
21GF Score
Get the complete analysis for BKK:MADAME
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:MADAME has been successfully added to your 
